Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink
Lorna Clarson, Samantha Hider, John Belcher, et al.
Annals of the Rheumatic Diseases (2014) Vol. 74, Iss. 4, pp. 642-647
Open Access | Times Cited: 113

Showing 26-50 of 113 citing articles:

Purification, identification, and computational analysis of xanthine oxidase inhibitory peptides from kidney bean
Yuqun Wu, Hui He, Tao Hou
Journal of Food Science (2021) Vol. 86, Iss. 3, pp. 1081-1088
Closed Access | Times Cited: 28
Gout and Cardiovascular Disease: Mechanisms, Risk Estimations, and the Impact of Therapies
Mariano Andrés
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 3, pp. 152-166
Open Access | Times Cited: 13
An association of smoking with serum urate and gout: A health paradox
Niamh Fanning, Tony R. Merriman, Nicola Dalbeth, et al.
Seminars in Arthritis and Rheumatism (2017) Vol. 47, Iss. 6, pp. 825-842
Closed Access | Times Cited: 38
Bidirectional Association between Self-Reported Hypertension and Gout: The Singapore Chinese Health Study
An Pan, Gim Gee Teng, Jian‐Min Yuan, et al.
PLoS ONE (2015) Vol. 10, Iss. 10, pp. e0141749-e0141749
Open Access | Times Cited: 36
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study
Jun‐ichi Oyama, Atsushi Tanaka, Yasunori Sato, et al.
Cardiovascular Diabetology (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 35
When gout goes to the heart: does gout equal a cardiovascular disease risk factor?
Jasvinder A. Singh
Annals of the Rheumatic Diseases (2015) Vol. 74, Iss. 4, pp. 631-634
Open Access | Times Cited: 34
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
Nan Liang, Mingshu Sun, Ruixia Sun, et al.
Arthritis Research & Therapy (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 33
Risk of cardiovascular events in patients having had acute calcium pyrophosphate crystal arthritis
Sara K. Tedeschi, Weixing Huang, Kazuki Yoshida, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 9, pp. 1323-1329
Open Access | Times Cited: 18
Treatment-Emergent Major Adverse Cardiovascular and Thromboembolic Events were Infrequent During Clinical Trials of Pegloticase
O. Troum, Mai Duong, K. Obermeyer, et al.
Lara D. Veeken (2025)
Closed Access
Risk of Sudden Sensorineural Hearing Loss in Patients with Gout: A Population-Level Study in a South Korean National Health Screening Cohort
Hyung-Bon Koo, Juyong Chung
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1094-1094
Open Access
Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data
Jasvinder A. Singh, John D. Cleveland
RMD Open (2018) Vol. 4, Iss. 2, pp. e000712-e000712
Open Access | Times Cited: 32
Gout is associated with organic and psychogenic erectile dysfunction
Chao-Yu Hsu, Cheng‐Li Lin, Chia‐Hung Kao
European Journal of Internal Medicine (2015) Vol. 26, Iss. 9, pp. 691-695
Closed Access | Times Cited: 29
Allopurinol Dose Escalation and Mortality Among Patients With Gout
Brian W. Coburn, Kaleb Michaud, Debra Bergman, et al.
Arthritis & Rheumatology (2018) Vol. 70, Iss. 8, pp. 1298-1307
Closed Access | Times Cited: 28
Mortality in Patients With Gout Treated With Allopurinol: A Systematic Review and Meta‐Analysis
Charles A. Hay, James A. Prior, John Belcher, et al.
Arthritis Care & Research (2020) Vol. 73, Iss. 7, pp. 1049-1054
Open Access | Times Cited: 24
Urate-Lowering Therapy Use among US Adults with Gout and the Relationship between Patients’ Gout Treatment Status and Associated Comorbidities
Marcos Ortiz-Uriarte, Jeanlouis Betancourt-Gaztambide, Alexandra Pérez, et al.
Rheumato (2023) Vol. 3, Iss. 1, pp. 74-85
Open Access | Times Cited: 9
Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements
Qianrui Li, Xiaodan Li, Joey Sum-Wing Kwong, et al.
BMJ Open (2017) Vol. 7, Iss. 6, pp. e014928-e014928
Open Access | Times Cited: 26
Work disability in gout: a population-based case–control study
Valgerður Sigurðardóttir, P. Drivelegka, Anna Svärd, et al.
Annals of the Rheumatic Diseases (2017) Vol. 77, Iss. 3, pp. 399-404
Closed Access | Times Cited: 25
Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis
Mihaela Gamala, Suzanne P. Linn-Rasker, Maarten Nix, et al.
Clinical Rheumatology (2018) Vol. 37, Iss. 7, pp. 1879-1884
Open Access | Times Cited: 25
Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study
M. Janssen, Paul G.J. Arts, Bianca W. M. Schalk, et al.
Joint Bone Spine (2016) Vol. 84, Iss. 1, pp. 59-64
Closed Access | Times Cited: 24
Ethanol Extract of Cudrania tricuspidata Leaf Ameliorates Hyperuricemia in Mice via Inhibition of Hepatic and Serum Xanthine Oxidase Activity
Seung-Hui Song, Dae-Hun Park, Min‐Suk Bae, et al.
Evidence-based Complementary and Alternative Medicine (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 24
Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure
Mallory T. Mouradjian, Michael E. Plazak, Stormi E. Gale, et al.
American Journal of Cardiovascular Drugs (2020) Vol. 20, Iss. 5, pp. 431-445
Closed Access | Times Cited: 21
Gout and the Risk of Incident Erectile Dysfunction: A Body Mass Index-matched Population-based Study
Naomi Schlesinger, Na Lu, Hyon K. Choi
The Journal of Rheumatology (2018) Vol. 45, Iss. 8, pp. 1192-1197
Closed Access | Times Cited: 21
Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study
Michael Toprover, Binita Shah, Cheongeun Oh, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease: A Nationwide Study of Veterans
Maaman Bashir, Katherine Sherman, Daniel H. Solomon, et al.
Arthritis Care & Research (2021) Vol. 75, Iss. 2, pp. 277-282
Closed Access | Times Cited: 17
Community-engaged randomised controlled trial to disseminate COVID-19 vaccine-related information and increase uptake among Black individuals in two US cities with rheumatic conditions
Greta Sirek, Daniel L. Erickson, Lutfiyya N. Muhammad, et al.
BMJ Open (2024) Vol. 14, Iss. 8, pp. e087918-e087918
Open Access | Times Cited: 2

Scroll to top